Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder

NCT02431806 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

552

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Placebo
DRUG: Levomilnacipran
DRUG: Fluoxetine

Sponsor

Forest Laboratories